Related Experiment Videos
Estrogen and parathyroid hormone regulate insulin-like growth factor binding protein-4 in SaOS-2 cells
1Department of Obstetrics and Gynecology, Tokyo Women's Medical College, Shinjuku, Japan.
Abstract:
The effect of 17beta-estradiol and parathyroid hormone (PTH) on the expression of insulin-like growth factor-binding protein-4 (IGFBP-4) messenger RNA (mRNA) was studied in the cultured human osteoblast-like SaOS-2 cells. Treatment of SaOS-2 cells with PTH for 3 h caused 3.3-fold increase in IGFBP-4 mRNA levels which was determined by reverse transcription-polymerase chain reaction. 17beta-Estradiol had no effect on either the stimulation of mRNA level by PTH or the basal level. Together with our previous report that 17beta-estradiol inhibits the PTH-induced reduction of IGFBP-4 proteolysis in these cells, the results obtained may help to explain the mechanisms of determining IGFBP-4 availability by systemic hormones in osteoblast cells.
Insights
Parathyroid hormone (PTH) significantly increases insulin-like growth factor-binding protein-4 (IGFBP-4) mRNA in human osteoblast cells. 17beta-estradiol did not affect this increase, suggesting distinct roles in regulating IGFBP-4 availability.
Area of Science:
- Endocrinology
- Molecular Biology
- Bone Biology
Background:
- Osteoblasts are crucial for bone health.
- Insulin-like growth factor-binding protein-4 (IGFBP-4) plays a role in bone metabolism.
- Systemic hormones like 17beta-estradiol and parathyroid hormone (PTH) influence osteoblast function.
Purpose of the Study:
- To investigate the effect of 17beta-estradiol and PTH on IGFBP-4 mRNA expression in human osteoblast-like SaOS-2 cells.
- To understand the interplay between these hormones in regulating IGFBP-4 availability.
Main Methods:
- Cultured human osteoblast-like SaOS-2 cells were treated with 17beta-estradiol and/or PTH.
- Insulin-like growth factor-binding protein-4 (IGFBP-4) messenger RNA (mRNA) levels were quantified using reverse transcription-polymerase chain reaction (RT-PCR).
Main Results:
- Parathyroid hormone (PTH) treatment for 3 hours resulted in a 3.3-fold increase in IGFBP-4 mRNA levels.
- 17beta-estradiol alone had no effect on basal IGFBP-4 mRNA levels.
- 17beta-estradiol did not alter the stimulatory effect of PTH on IGFBP-4 mRNA levels.
Conclusions:
- Parathyroid hormone (PTH) directly upregulates IGFBP-4 mRNA expression in osteoblasts.
- 17beta-estradiol does not modulate PTH-induced IGFBP-4 mRNA expression.
- These findings contribute to understanding how systemic hormones regulate IGFBP-4 availability in bone cells.